These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11167782)

  • 1. Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.
    Tavazzi D; Duca L; Graziadei G; Comino A; Fiorelli G; Cappellini MD
    Br J Haematol; 2001 Jan; 112(1):48-50. PubMed ID: 11167782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia.
    Cappellini MD; Tavazzi D; Duca L; Graziadei G; Mannu F; Turrini F; Arese P; Fiorelli G
    Br J Haematol; 1999 Mar; 104(3):504-12. PubMed ID: 10086787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassaemic erythrocytes: cellular suicide arising from iron and glutathione-dependent oxidation reactions?
    Scott MD; Eaton JW
    Br J Haematol; 1995 Dec; 91(4):811-9. PubMed ID: 8547123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocytes anion transport and oxidative change in beta-thalassaemias.
    Maria C; Leonardo R; Pietro R; Mario V; Isabella V; Diana T
    Cell Biol Int; 2010 May; 34(6):655-62. PubMed ID: 20450494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients.
    Agouti I; Cointe S; Robert S; Judicone C; Loundou A; Driss F; Brisson A; Steschenko D; Rose C; Pondarré C; Bernit E; Badens C; Dignat-George F; Lacroix R; Thuret I
    Br J Haematol; 2015 Nov; 171(4):615-24. PubMed ID: 26205481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-mediated oxidative stress in erythrocytes.
    Rice-Evans C; Baysal E
    Biochem J; 1987 May; 244(1):191-6. PubMed ID: 3663112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labile iron pool as a parameter to monitor iron overload and oxidative stress status in β-thalassemic erythrocytes.
    Chutvanichkul B; Vattanaviboon P; Mas-Oodi S; U-Pratya Y; Wanachiwanawin W
    Cytometry B Clin Cytom; 2018 Jul; 94(4):631-636. PubMed ID: 29486524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia.
    de Franceschi L; Turrini F; Honczarenko M; Ayi K; Rivera A; Fleming MD; Law T; Mannu F; Kuypers FA; Bast A; van der Vijgh WJ; Brugnara C
    Haematologica; 2004 Nov; 89(11):1287-98. PubMed ID: 15531450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-haem iron-mediated oxidative stress in haemoglobin E beta-thalassaemia.
    Chakraborty I; Mitra S; Gachhui R; Kar M
    Ann Acad Med Singap; 2010 Jan; 39(1):13-6. PubMed ID: 20126808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron release in erythrocytes from patients with beta-thalassemia.
    Ciccoli L; Signorini C; Scarano C; Rossi V; Bambagioni S; Ferrali M; Comporti M
    Free Radic Res; 1999 May; 30(5):407-13. PubMed ID: 10342333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo metabolic studies of glucose, ATP and 2,3-DPG in beta-thalassaemia intermedia, heterozygous beta-thalassaemic and normal erythrocytes: 13C and 31P MRS studies.
    Ting YL; Naccarato S; Qualtieri A; Chidichimo G; Brancati C
    Br J Haematol; 1994 Nov; 88(3):547-54. PubMed ID: 7819067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of beta-thalassaemic erythrocytes from oxidative stress by propionyl carnitine.
    Palmieri L; Ronca F; Malengo S; Bertelli A
    Int J Tissue React; 1994; 16(3):121-9. PubMed ID: 7852033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of circulating β-thalassaemia/haemoglobin E extra-cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation.
    Phongpao K; Pholngam N; Chokchaichamnankit D; Nuamsee K; Praneetponkang R; Ounjai P; Paiboonsukwong K; Siwaponanan P; Pattanapanyasat K; Svasti J; Srisomsap C; Weeraphan C; Chaichompoo P; Svasti S
    Br J Haematol; 2024 May; 204(5):2025-2039. PubMed ID: 38613149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleic acid prevents erythrocyte death by preserving haemoglobin and erythrocyte membrane proteins.
    Banerjee A; Dey T; Majumder R; Bhattacharya T; Dey S; Bandyopadhyay D; Chattopadhyay A
    Free Radic Biol Med; 2023 Jun; 202():17-33. PubMed ID: 36965537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients.
    Ferro E; Visalli G; La Rosa MA; Civa R; Papa GR; D'Ascola DG; Roccamo G; Piraino B; Salpietro C; Di Pietro A
    Hematology; 2017 Apr; 22(3):183-191. PubMed ID: 27801288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peculiarities of iron metabolism in patients with Beta - thalassemia at different periods after splenectomy].
    Kadimova E
    Georgian Med News; 2007 Nov; (152):35-7. PubMed ID: 18175831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron release, oxidative stress and erythrocyte ageing.
    Comporti M; Signorini C; Buonocore G; Ciccoli L
    Free Radic Biol Med; 2002 Apr; 32(7):568-76. PubMed ID: 11909691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in β-thalassaemia and sickle cell disease.
    Voskou S; Aslan M; Fanis P; Phylactides M; Kleanthous M
    Redox Biol; 2015 Dec; 6():226-239. PubMed ID: 26285072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia.
    Domenica Cappellini M; Tavazzi D; Duca L; Marelli S; Fiorelli G
    Transfus Sci; 2000 Dec; 23(3):245-6. PubMed ID: 11099903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.